MedTrace Logo

Pilot Study of the Coronary Spur Stent for In-stent Restenosis (DEEPER CORONARY)

NCT06117150 · Status: ACTIVE_NOT_RECRUITING · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2025-08-08

No results posted yet for this study

Summary

To demonstrate acceptable short term safety rates of the Drug-eluting Coronary Spur Stent System as a primary treatment for coronary in-stent restenosis.

Conditions

  • In-stent Restenosis

Interventions

DEVICE

Drug-eluting Coronary Spur Stent System

All subjects enrolled will be treated with the Drug-eluting Coronary Spur Stent System.

Sponsors & Collaborators

  • ReFlow Medical, Inc.

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-06-09
Primary Completion
2026-06-30
Completion
2026-07-31

Countries

  • New Zealand

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06117150 on ClinicalTrials.gov